Impact of BECLIN1 haploinsufficiency on goblet cell function and susceptibility to colitis.
Saved in:
| Title: | Impact of BECLIN1 haploinsufficiency on goblet cell function and susceptibility to colitis. |
|---|---|
| Authors: | Juliani J; Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, Australia.; La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia.; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Tran S; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Harris TJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Ellis SL; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Al-Ani AH; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; University of Melbourne, Parkville, VIC, Australia.; Royal Melbourne Hospital, Parkville, VIC, Australia., Wijebandara Y; Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, Australia.; La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia., Patel KM; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Young SN; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia., Evangelista M; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Baloyan D; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Reehorst CM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Nightingale R; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Jenkins LJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., De Cruz P; Department of Gastroenterology, Austin Health, Melbourne, VIC, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, VIC, Australia., Duszyc K; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD, Australia., Kile BT; Garvan Institute of Medical Research, Darlinghurst, NSW, Australia., Yap AS; Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Brisbane, QLD, Australia., Mariadason JM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia., Christensen B; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; University of Melbourne, Parkville, VIC, Australia.; Royal Melbourne Hospital, Parkville, VIC, Australia., Samson AL; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; University of Melbourne, Parkville, VIC, Australia., Murphy JM; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.; University of Melbourne, Parkville, VIC, Australia.; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia., Fairlie WD; Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, Australia. Doug.Fairlie@onjcri.org.au.; La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia. Doug.Fairlie@onjcri.org.au.; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. Doug.Fairlie@onjcri.org.au.; School of Cancer Medicine, La Trobe University, Bundoora, VIC, Australia. Doug.Fairlie@onjcri.org.au., Lee EF; Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, Australia. Erinna.Lee@latrobe.edu.au.; La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia. Erinna.Lee@latrobe.edu.au. |
| Source: | Cell death & disease [Cell Death Dis] 2026 Jun 17; Vol. 17 (1). Date of Electronic Publication: 2026 Jun 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
